Cheryl Kyinn
Medical · San Diego, CANPI 1649570284
Payments from drug & device makers
Across 1,310 payments — averaging $78.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$50K
- AbbVie$25K
- Amneal Pharmaceuticals LLC$8K
- Teva Pharmaceuticals USA, Inc.$3K
- MDD US Operations, LLC$2K
- Boston Scientific$1K
- plus $12K from 28 others
What the payments were for
- Consulting fees$17,87717%
- Speaking & faculty fees$44,18643%
- Travel & lodging$10,82011%
- Food & beverage$29,37329%
- Education$3380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 249 | $50,422 |
| AbbVie(2 entities) | 332 | $25,022 |
| Amneal Pharmaceuticals LLC | 90 | $8,344 |
| Teva Pharmaceuticals USA, Inc. | 143 | $2,875 |
| MDD US Operations, LLC | 66 | $2,284 |
| Boston Scientific | 24 | $1,445 |
| Tanabe Pharma America, Inc. | 2 | $1,320 |
| Neurocrine Biosciences, Inc. | 51 | $1,319 |
| Adamas Pharmaceuticals, Inc. | 10 | $1,236 |
| Medtronic | 30 | $997 |
| Merz Pharmaceuticals, LLC | 35 | $958 |
| Kyowa Kirin, Inc. | 39 | $915 |
| Pfizer | 51 | $707 |
| Ipsen Biopharmaceuticals, Inc | 27 | $524 |
| Global Kinetics USA Corporation | 1 | $500 |
| Lilly USA, LLC | 18 | $451 |
| Biohaven Pharmaceuticals, Inc. | 22 | $424 |
| Acorda Therapeutics, Inc | 26 | $356 |
| Avadel CNS Pharmaceuticals, LLC | 10 | $344 |
| Abbott | 7 | $284 |
| Avion Pharmaceuticals | 22 | $251 |
| Supernus Pharmaceuticals, Inc. | 4 | $242 |
| Impel Pharmaceuticals Inc. | 6 | $213 |
| Biohaven Pharmaceutical Holding Company Ltd. | 15 | $209 |
| Eisai Inc. | 6 | $208 |
| Insightec,inc | 1 | $159 |
| UCB, Inc. | 7 | $133 |
| Amgen | 6 | $123 |
| Axsome Therapeutics, Inc. | 4 | $107 |
| Biogen | 1 | $89 |
| Hologic Sales And Service, LLC | 1 | $51 |
| Impel Pharmaceuticals LLC | 2 | $43 |
| Cala Health, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$102,595 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 147 | $786,101 |
| IngrezzaValbenazine Tosylate | 12 | $169,951 |
| Austedo XrDeutetrabenazine | 28 | $167,189 |
| GocovriAmantadine Hcl | 53 | $157,355 |
| RytaryCarbidopa/Levodopa | 204 | $154,332 |
| NourianzIstradefylline | 41 | $131,648 |
| OngentysOpicapone | 88 | $100,366 |
| InbrijaLevodopa | 16 | $73,039 |
| NeuproRotigotine | 40 | $64,138 |
| Rasagiline Mesylate | 170 | $40,351 |
| UbrelvyUbrogepant | 19 | $27,501 |
| CrexontCarbidopa/Levodopa | 31 | $24,129 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 481 | $19,061 |
| Pramipexole ErPramipexole Di-Hcl | 55 | $15,962 |
| Ajovy SyringeFremanezumab-Vfrm | 13 | $15,053 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Acadia Pharmaceuticals IncNuplazid | $50,422 | $786,101147 claims |
| Neurocrine Biosciences, Inc.Ingrezza, Ongentys | $1,319 | $270,316100 claims |
| Amneal Pharmaceuticals LLCRytary, Crexont | $8,344 | $178,461235 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $2,875 | $167,18928 claims |
| MDD US Operations, LLCGocovri | $2,284 | $157,35553 claims |
| Kyowa Kirin, Inc.Nourianz | $915 | $131,64841 claims |
| Acorda Therapeutics, IncInbrija | $356 | $73,03916 claims |
| UCB, Inc.Neupro | $133 | $64,13840 claims |
| AbbVieUbrelvy | $25,022 | $27,50119 claims |
| Avion PharmaceuticalsDhivy | $251 | $8,73129 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 medical providers in California.
Other medical in San Diego
- Touraj YariSan Diego$27K
- Aaron WillcottSan Diego$23K
- Yuchao JinSan Diego$22K
- Carter CopelandSan Diego$17K
- Cameron ChanSan Diego$16K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.